$CRMD recovery candle. $2.02/$2.86 Website h
Post# of 63818
Posted On: 01/29/2015 10:33:20 AM
$CRMD recovery candle . $2.02/$2.86
Website
72 % Buy
detailed opinion
Shares Outstanding: 22.18M
Float: 19.18M
% Held by Insiders: 16.31%
% Held by Institutions: 9.20%
Shares Short (as of Jan 15, 2015): 417.40K
Short Ratio (as of Jan 15, 2015)3 4.40
Short % of Float (as of Jan 15, 2015)3: 2.00%
Shares Short (prior month)3: 411.97K
10-Q 8/14/14
Summary
Recent trades
Headlines
Thursday, January 29, 2015
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu 9:20AM EST)
FDA Grants QIDP Designation to Neutrolin®, CorMedix Inc.'s Lead Product Candidate in the U.S.PR Newswire (Thu 9:00AM EST)
Tuesday, January 20, 2015
CORMEDIX INC. Files SEC form 8-K, Other EventsEDGAR Online (Tue, Jan 20)
Thursday, January 15, 2015
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Jan 15)
CorMedix Inc. Receives Fast Track Designation for Neutrolin®PR Newswire (Thu, Jan 15)
CorMedix (CRMD) Shows Strength: Stock Moves Up 14.6% - Tale of the TapeZacks (Thu, Jan 15)
Monday, January 12, 2015
CORMEDIX INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 12)
Tuesday, December 23, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Dec 23)
CorMedix Inc. Finalizes First Middle East Neutrolin® Sales/Distribution Agreement in the Kingdom of Saudi ArabiaPR Newswire (Tue, Dec 23)
Thursday, December 4, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Dec 4)
CorMedix Inc. Files Request with FDA for QIDP Designation for Neutrolin®PR Newswire (Thu, Dec 4)
Wednesday, December 3, 2014
Neutrolin Label Expansion Approved in GermanyPR Newswire (Wed, Dec 3)
Friday, November 21, 2014
CORMEDIX INC. FinancialsEDGAR Online Financials (Fri, Nov 21)
Thursday, November 13, 2014
CORMEDIX INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 13)
Q3 2014 CorMedix Inc Earnings Release - Time Not SuppliedCCBN (Thu, Nov 13)
Thursday, November 6, 2014
CorMedix, Inc. to Announce Third Quarter 2014 Results on November 13, 2014; Conference call hosted at 9 am on Friday, November 14, 2014PR Newswire (Thu, Nov 6)
Monday, October 27, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Oct 27)
CorMedix Receives Approval From FDA to Initiate a Clinical Trial for Neutrolin in the USMarketwired (Mon, Oct 27)
Thursday, September 25, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Sep 25)
CorMedix Announces FDA IND Filing for Neutrolin® in United StatesPR Newswire (Thu, Sep 25)
Website
72 % Buy
detailed opinion
Shares Outstanding: 22.18M
Float: 19.18M
% Held by Insiders: 16.31%
% Held by Institutions: 9.20%
Shares Short (as of Jan 15, 2015): 417.40K
Short Ratio (as of Jan 15, 2015)3 4.40
Short % of Float (as of Jan 15, 2015)3: 2.00%
Shares Short (prior month)3: 411.97K
10-Q 8/14/14
Summary
Recent trades
Headlines
Thursday, January 29, 2015
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu 9:20AM EST)
FDA Grants QIDP Designation to Neutrolin®, CorMedix Inc.'s Lead Product Candidate in the U.S.PR Newswire (Thu 9:00AM EST)
Tuesday, January 20, 2015
CORMEDIX INC. Files SEC form 8-K, Other EventsEDGAR Online (Tue, Jan 20)
Thursday, January 15, 2015
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Jan 15)
CorMedix Inc. Receives Fast Track Designation for Neutrolin®PR Newswire (Thu, Jan 15)
CorMedix (CRMD) Shows Strength: Stock Moves Up 14.6% - Tale of the TapeZacks (Thu, Jan 15)
Monday, January 12, 2015
CORMEDIX INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 12)
Tuesday, December 23, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Dec 23)
CorMedix Inc. Finalizes First Middle East Neutrolin® Sales/Distribution Agreement in the Kingdom of Saudi ArabiaPR Newswire (Tue, Dec 23)
Thursday, December 4, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Dec 4)
CorMedix Inc. Files Request with FDA for QIDP Designation for Neutrolin®PR Newswire (Thu, Dec 4)
Wednesday, December 3, 2014
Neutrolin Label Expansion Approved in GermanyPR Newswire (Wed, Dec 3)
Friday, November 21, 2014
CORMEDIX INC. FinancialsEDGAR Online Financials (Fri, Nov 21)
Thursday, November 13, 2014
CORMEDIX INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 13)
Q3 2014 CorMedix Inc Earnings Release - Time Not SuppliedCCBN (Thu, Nov 13)
Thursday, November 6, 2014
CorMedix, Inc. to Announce Third Quarter 2014 Results on November 13, 2014; Conference call hosted at 9 am on Friday, November 14, 2014PR Newswire (Thu, Nov 6)
Monday, October 27, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Oct 27)
CorMedix Receives Approval From FDA to Initiate a Clinical Trial for Neutrolin in the USMarketwired (Mon, Oct 27)
Thursday, September 25, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Sep 25)
CorMedix Announces FDA IND Filing for Neutrolin® in United StatesPR Newswire (Thu, Sep 25)
(0)
(0)